Clin2
NCT06145711Possibly a fitRecruiting

Stem cell therapy for Parkinson's disease

Parkinson's Disease

Part of Brain & nervous system clinical trials.

This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3 people
Ages
30 years to 70 years
Study type
Interventional

Who can take part

  • You have had Parkinson's disease for at least 5 years.
  • You are between 30 and 70 years old.
  • Levodopa used to help your symptoms, but now it wears off or doesn't work as well.
  • You have not had deep brain stimulation (DBS) or similar brain surgery.
  • You have a caregiver who can help with your care and information.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05901818Recruiting· Phase 1
Testing a patient’s own stem-cell treatment for Parkinson’s

This Phase 1 study tests whether an “autologous” (from your own body) iNSC-DAP stem-cell treatment is safe and may help symptoms in Parkinson’s disease. It is designed mainly to check safety, while also watching for signs of improvement.

Beijing, Beijing Municipality
NCT06753331Recruiting· Phase 1/Phase 2
Study of DSP-1083 for Parkinson's disease

This trial tests a new treatment called DSP-1083 for people with Parkinson's disease whose symptoms are not well controlled with standard medications. The study will check if it is safe and if it helps improve movement and daily function.

Lexington, Kentucky
NCT06821529Not yet recruiting· Phase 1
Cell injection for Parkinson's disease

This early-stage trial tests a new treatment where specialized cells are injected directly into the brain. It is for people with advanced Parkinson's who have been on levodopa for a while and experience 'off' periods or involuntary movements.

Hangzhou, Zhejiang
NCT07166757Recruiting· Phase 1/Phase 2
Study of XS411 for early-onset Parkinson's disease

This trial tests a new treatment called XS411 for people with early-onset Parkinson's disease (age 50 or younger at diagnosis). It is for those whose motor symptoms are not well controlled with standard medications and who may benefit from a neurosurgical procedure.

Shanghai, Shanghai Municipality
NCT06687837Recruiting· Phase 1
Stem cell therapy for Parkinson's disease

This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.

Boston, Massachusetts
NCT07232147Not yet recruiting· Phase 1
Stem cell therapy for Parkinson's disease

This study tests a new stem cell treatment for Parkinson's disease. It aims to see if the treatment is safe and may help improve symptoms when current medications stop working well.

Hear when a new Parkinson’s disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.